Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Allotera Therapeutics

Clinical trials sponsored by Allotera Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Donor immune cells take on tough T-Cell cancers in new trial Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Donor immune cells take on tough T-Cell cancers in new trial

Disease control Recruiting now

This phase 2 trial tests a one-time infusion of WU-CART-007, a CAR-T cell therapy made from healthy donor cells, in 125 people with T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma that has come back or not responded to treatment. The goal is to see if it can wipe ou…

Phase 2 • Sponsor: Allotera Therapeutics • Aim: Disease control

Last updated Sep 05, 2026 00:00 UTC